Measles, mumps, and rubella (MMR) vaccine and autism. Argument is too simplistic
Edwardes, M.; Baltzan, M.
Bmj 323(7305): 163; Author Reply 164
2001
ISSN/ISBN: 0959-8138 PMID: 11484721 Document Number: 526559
Document emailed within 1 workday
Related Documents
da Silveira, C.Marcos.; Kmetzsch, C.Iris.; Mohrdieck, R.; Sperb, A.Fagundes.; Prevots, D.Rebecca. 2002: The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997 International Journal of Epidemiology 31(5): 978-982Trotter, A.C.; Stone, B.D.; Laszlo, D.J.; Georgitis, J.W. 1994: Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization Annals of Allergy 72(1): 25-28
Lamabadusuriya, S.P. 2011: Measles, mumps, rubella (MMR) vaccine Ceylon Medical Journal 56(3): 135
Stück, B.; Stehr, K.; Bock, H.L. 2002: Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age Asian Pacific Journal of Allergy and Immunology 20(2): 113-120
Lang, S. 1998: Measles, mumps, rubella vaccine and allergy to egg American Family Physician 58(4): 863-864
Brunell, P.A.; Novelli, V.M.; Lipton, S.V.; Pollock, B. 1988: Combined vaccine against measles, mumps, rubella, and varicella Pediatrics 81(6): 779-784
Gatchalian, S.; Tabora, C.; Bermal, N.; Leboulleux, D.; Desauziers, E. 2004: Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old American Journal of Tropical Medicine and Hygiene 70(3): 273-277
Topal, B.; Kanra, G.; Ceyhan, M. 1991: Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine Turkish Journal of Pediatrics 33(1): 13-18
Kornbrot, B.; Levy, Y.; Garty, B.Z.; Danon, Y.L. 1990: Allergic reactions to measles, mumps and rubella vaccine in children with egg protein allergy Harefuah 119(7-8): 230-231
Just, M.; Berger, R.; Glück, R.; Wegmann, A. 1985: Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella Schweizerische Medizinische Wochenschrift 115(48): 1727-1730
Vázquez Fernández, E.; López Rois, F.; Vázquez Carrete, J.A.; Gómez Tato, B.; Alvarez Ares, M. 1987: Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old Anales Espanoles de Pediatria 27(1): 27-31
Trier, H.; Rønne, T. 1992: Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella Ugeskrift for Laeger 154(29): 2008-2013
Gatchalian, S.; Cordero-Yap, L.; Lu-Fong, M.; Soriano, R.; Ludan, A.; Chitour, K.; Bock, H.L. 1999: A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age Southeast Asian Journal of Tropical Medicine and Public Health 30(3): 511-517
Cameron, N.A. 2012: When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa? Vaccine 30 Suppl. 3: C58-C60
Rotily, M.; Guagliardo, V.; Fontaine, D.; Garros, B.; Mayer, C.; Arrighi, J.; Woronoff, A.S.; Ledesert, B.; Lepec, R.; Chabaud, F.; Janvrin, M.P.; Baudier, F. 2001: Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors Revue d'Epidemiologie et de Sante Publique 49(4): 331-341
Senterre, J. 1999: Drug clinics. Drug of the month. A new measles-rubella-mumps vaccine (Priorix) Revue Medicale de Liege 54(2): 122-124
He, H.; Chen, E.; Chen, H.; Wang, Z.; Li, Q.; Yan, R.; Guo, J.; Zhou, Y.; Pan, J.; Xie, S. 2014: Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children Vaccine 32(31): 4001-4005
Heller, T. 2001: Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? how safe is MMR vaccine? Bmj 323(7317): 838-839; Discussion 840
Rose, V.L. 1998: ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps American Family Physician 58(7): 1682; 1685-1686
Ruíz-Gómez, J.; Espinosa-Larios, E.L. 1978: Seroepidemiology of rubella, measles and mumps in the Republic of Mexico. IV. Rubella Salud Publica de Mexico 20(1): 29-33